Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Noetik

Biotech & Life Sciences · South San Francisco, United States · Founded 2022

Noetik.ai is an AI-native biotechnology company focused on revolutionizing cancer treatment through the development of precision immunotherapies. The company leverages advanced machine learning techniques to analyze complex tumor-immune interactions, which traditional reductionist approaches fail to capture. By combining self-supervised learning with the large-scale generation of human multimodal data, Noetik aims to create foundational models for cell and tissue biology that drive therapeutic development. This innovative approach allows Noetik to enter a new era of drug discovery, where AI is not just used to enhance human tasks but to achieve what humans alone cannot. Noetik serves the biotechnology and pharmaceutical sectors, targeting clients who are looking for cutting-edge cancer treatment solutions. The company operates in the precision medicine market, focusing on immunotherapies tailored to individual patients. Noetik's business model involves partnering with pharmaceutical companies and healthcare providers to develop and commercialize its AI-driven therapies. Revenue is generated through licensing agreements, research collaborations, and the sale of proprietary therapeutic solutions. Keywords: AI-native, biotechnology, precision immunotherapies, cancer treatment, machine learning, tumor-immune interactions, self-supervised learning, multimodal data, drug discovery, precision medicine.

Valuation
$100–500M
Latest valuation · 2024
Unlock exact value
Headcount
<100
Current team size
Unlock exact value
Total funding Pre-IPO
$50–100M
Unlock exact value

Investors

21 investors on Noetik's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 13 investors entered at this stage
DCVC
Hummingbird Ventures
Zetta Venture Partners
EPIC Ventures
Viswa Colluru
Intermountain Ventures
CJNV BioVenture
Michael Secora
11.2 Capital
Chris Gibson
Catalio Capital Management
North South Ventures
Chau Khuong
Series A 8 investors entered at this stage
Amy Schulman
Polaris Partners
Jean-Francois Gagné
Wittington Ventures
Linearis
Khosla Ventures
Breakout Ventures
ApSTAT Technologies

Global footprint

Where Noetik has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States97.5%
🇨🇦 Canada2.5%
2 countries shown

Talent graph

The shape of Noetik's talent

Dealroom maps Noetik's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

6 team members profilednamed & role-tagged by Dealroom
49 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Noetik's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Noetik

An AI-synthesized read of the highest-engagement posts about Noetik on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Noetik on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.